Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Comparative Effectiveness Reviews Will Expand Beyond Medicare

Executive Summary

The Agency for Healthcare Research & Quality is preparing to expand the scope of its comparative effectiveness reviews beyond the Medicare population
Advertisement

Related Content

PPIs Get AHRQ Stamp Of Approval Vs. Surgery; Generics Could Be Big Winners
CATIE Suggests Zyprexa Useful As Initial Schizophrenia Treatment – NEJM
AHRQ Drug Effectiveness Comparisons Will Focus On 10 “Priority Conditions”
AHRQ Drug Effectiveness Comparisons Will Focus On 10 “Priority Conditions”
Advertisement
UsernamePublicRestriction

Register

PS046752

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel